ClinicalTrials.Veeva

Menu

Multicenter and Open Pilot Clinical Study on the Safety of a New One-piece Convex Appliance in Patients With Enterostomy

B. Braun logo

B. Braun

Status

Completed

Conditions

Enterostomy

Treatments

Device: Flexima Active soft convexe

Study type

Interventional

Funder types

Industry

Identifiers

NCT02507726
OPM-G-H-1501

Details and patient eligibility

About

This study evaluates the performance of a new 1-piece ostomy convex appliance in patients with enterostomy.

Full description

Primary outcome Measure:

To describe Investigational Device performance in term of level of leakage under the skin protector

Secondary Outcome Measure:

  • Assessment of the condition of peristomal skin
  • Assessment of other performance criteria
  • Assessment of AEs for each patient

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient is at least 18 years old,
  • patient having a colostomy or an ileostomy for at least 1 month,
  • patient having a stoma's diameter inferior to 45 mm,
  • patient having a flat or flushed or slightly retracted stoma,
  • patient using currently a one-piece soft convex or standard ostomy appliance with closed or drainable bags,
  • patient using a minimum of 1 product per day with closed pouches or minimum 1 product per two days with drainable pouches
  • patient capable to apply and remove the pouch himself or with the help of a caregiver (except health care professional)
  • patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions)
  • patient agreeing to test investigational product during 14(±3) days.
  • patient covered by social security

Exclusion criteria

  • patient experiencing repeated leakages with his current appliance,
  • patient receiving or having received, within the last month, chemotherapy or radiotherapy or corticotherapy,
  • patient having a deeply retracted stoma,
  • patient currently suffering from peristomal skin complications (bleeding or severe irritation or red and broken skin at the time of inclusion),
  • patient already participating in another clinical study or who have previously participated in this investigation,
  • pregnant or breast-feeding woman

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Flexima Active Soft convexe
Experimental group
Description:
Flexima Active soft convexe (1 to 3 appliances per day)
Treatment:
Device: Flexima Active soft convexe

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems